Ann: Roquefort Therapeutics Announcement and Voluntary Susp, page-4

"...for the sale of Lyramid to Pleiades Pharma Limited, with completion “contingent inter alia on
Pleaides completing a current fundraising roundand finalising certain in-licensing transactions”. It
is also noted that “post completion of the proposed transaction Roquefort Therapeutics will hold a
material equity position in Pleiades, a private well-funded company with a portfolio of clinical
assets and pre-clinical programs”.

My obvious question is .... if they are a "private, well funded company" - why do they have to make the acquisition "contingent" on being able to raise more capital?

Poor ole' Lyramid, the poor buggers must feel like the proverbial corporate whore while these wannabe's play their funny games.